We are excited to announce the official launch of the Global Development Token (GDT) website. Here, you can explore our mission to complete a cure for diabetes, learn about the innovative Biozipcode™ technology, and stay updated on our latest news and project milestones. Visit regularly to discover new insights, upcoming events, and opportunities to join ...

May 22, 2025 — Research originating from Shiga University of Medical Science and its spin-off Biozipcode, Inc. has been highlighted in major Japanese media, including Yahoo! News Japan and ASCII.jp. The coverage focused on a promising new therapeutic approach to diabetes that aims not only to manage blood sugar but to fundamentally repair the abnormal ...

This week in Dubai marked an important step toward advancing our mission to achieve a complete cure for diabetes. We had the privilege of welcoming H.E. Peter Adelbai, Ambassador of the Republic of Palau to Japan, and Professor Hideto Kojima of Shiga University of Medical Science. The gathering, held together with Mr. James Park, Managing ...

Our team recently visited the Republic of Palau with a clear mission: to establish the nation as a model country for achieving a complete cure for diabetes. The delegation included members from Shiga University of Medical Science, former Minister for IT Policy and former Member of the House of Representatives Mr. Naokazu Takemoto, and Mr. ...

Silicon Valley, USA — We were honored to present at the Japan Innovation Campus, an initiative hosted by the Ministry of Economy, Trade and Industry (METI), operated by Mori Building Co., Ltd. and Mori Building Palo Alto, Inc., and partnered with JETRO. The event serves as a bridge between Japan’s most promising ventures and leading ...

July 29, 2024 — Professor Hideto Kojima of Shiga University of Medical Science delivered a featured presentation on Biozipcode™ technology at an international conference focused on gene therapy. The session, organized by SLDDDRS and AnGes, gathered more than 20 representatives from key Japanese and U.S. research agencies, including JST, AMED, JSPS, JETRO, NEDO, NICT, NIH, ...

June 2024 — At ENDO 2024, the annual meeting of the Endocrine Society and one of the world’s leading gatherings of endocrinology experts, our research team presented a scientific poster entitled “Diabetes Stem Cells: A Common Target for Abnormal Insulin Secretion and Insulin Resistance.” This year’s meeting attracted thousands of scientists, clinicians, and industry leaders ...

May 2024 — At the 67th Annual Scientific Meeting of the Japan Diabetes Society (JDS 2024), held in Tokyo from May 17–19, Professor Hideto Kojima and his team from the Department of Regenerative Medicine Development and the Department of Biomedical Informatics at Shiga University of Medical Science presented groundbreaking findings on the discovery of Diabetes ...

July 2024 — Professor Hideto Kojima of Shiga University of Medical Science, together with members of his research team, visited the KIYAN PHARMA Co., Ltd. manufacturing facility in Fukuroi, Japan. The visit marked an important milestone in strengthening collaboration between academia and industry toward the goal of developing a curative therapy for diabetes. During the ...